Table 2 Clinicopathological features of the cohort study

Range

21-85

Age

≥50,n (%)

68; 59.13%

<50, n(%)

47; 40.87%

Histology

Serous

50

Benign

40

Control

25

OC FIGO stage

I

4

II

4

III

20

IV

22

Lymph node metastasis

Negative

15

Positive

35

Residual tumor

Yes

50

no

0

Position, n (%)

Bilateral

32; (65.7%)

Unilateral

18; (34.3%)